Caracterização mecânica e estrutural de um dispositivo PDLC baseado em hidrogéis de PAAm e cristal líquido liotrópico LP/DeOH/H2O

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Boa colocação da equação quase-geostrófica em Lp-fraco

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

The crystal field strength parameter and the maximum splitting of the 7F1 manifold of the Eu3+ ion in oxides

We examine, from both the experimental and theoretical point of view, the behavior of the maximum splitting ΔE, of the 7F1 manifold of the Eu3+ ion as a function of the so-called crystal field strength parameter, Nv, in a series of oxides. In connection with the original theory that describes the relation between ΔE and Nv, a more consistent procedure to describe this relation is presented for the cases of small total angular momentum J. Good agreement is found between theory and experiment. © 1995.

Bianchi identities for an N=2, d=5 supersymmetric Yang-Mills theory on the group manifold

The purpose of this note is the construction of a geometrical structure for a supersymmetric N = 2, d = 5 Yang-Mills theory on the group manifold. From a general hypothesis proposed for the curvatures of the theory, the Bianchi identities are solved, whose solution will be fundamental for the construction of the geometrical action for the N = 2, d = 5 supergravity and Yang-Mills coupled theory.

Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase A2 (Lp-PLA2 ): a review

The association of cardiovascular events with Lp-PLA2 has been studied continuously today. The enzyme has been strongly associated with several cardiovascular risk markers and events. Its discovery was directly related to the hydrolysis of the platelet-activating factor and oxidized phospholipids, which are considered protective functions. However, the hydrolysis of bioactive lipids generates lysophospholipids, compounds that have a pro-inflammatory function. Therefore, the evaluation of the distribution of Lp-PLA2 in the lipid fractions emphasized the dual role of the enzyme in the inflammatory process, since the HDL-Lp-PLA2 enzyme contributes to the reduction of atherosclerosis, while LDL-Lp-PLA2 stimulates this process. Recently, it has been verified that diet components and drugs can influence the enzyme activity and concentration. Thus, the effects of these treatments on Lp-PLA2 may represent a new kind of prevention of cardiovascular disease. Therefore, the association of the enzyme with the traditional assessment of cardiovascular risk may help to predict more accurately these diseases.

Influence of obesity and cardiometabolic makers on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in adolescents: the healthy young cross-sectional study

Abstract Background Lipoprotein-associated phospholipase A2 activity (Lp-PLA2) is a good marker of cardiovascular risk in adults. It is strongly associated with stroke and many others cardiovascular events. Despite this, the impact of obesity on this enzyme activity and its relation to biomarkers of cardiovascular disease in adolescents is not very well investigated. The purpose of this article is to evaluate the influence of obesity and cardiometabolic markers on Lp-PLA2 activity in adolescents. Results This cross-sectional study included 242 adolescents (10–19 years) of both gender. These subjects were classified in Healthy Weight (n = 77), Overweight (n = 82) and Obese (n = 83) groups. Lipid profile, glucose, insulin, HDL size, LDL(−) and anti-LDL(−) antibodies were analyzed. The Lp-PLA2 activity was determined by a colorimetric commercial kit. Body mass index (BMI), waist circumference and body composition were monitored. Food intake was evaluated using three 24-hour diet recalls. The Lp-PLA2 activity changed in function to high BMI, waist circumference and fat mass percentage. It was also positively associated with HOMA-IR, glucose, insulin and almost all variables of lipid profile. Furthermore, it was negatively related to Apo AI (β = −0.137; P = 0.038) and strongly positively associated with Apo B (β = 0.293; P < 0.001) and with Apo B/Apo AI ratio (β = 0.343; P < 0.001). The better predictor model for enzyme activity, on multivariate analysis, included Apo B/Apo AI (β = 0.327; P < 0.001), HDL size (β = −0.326; P < 0.001), WC (β = 0.171; P = 0.006) and glucose (β = 0.119; P = 0.038). Logistic regression analysis demonstrated that changes in Apo B/Apo AI ratio were associated with a 73.5 times higher risk to elevated Lp-PLA2 activity. Conclusions Lp-PLA2 changes in function of obesity, and that it shows important associations with markers of cardiovascular risk, in particular with waist circumference, glucose, HDL size and Apo B/Apo AI ratio. These results suggest that Lp-PLA2 activity can be a cardiovascular biomarker in adolescence.

Die Rolle der Autoimmunreaktion gegen das SLA/LP-Molekül bei autoimmuner Hepatitis

In der vorliegenden Arbeit wurde die Rolle des SLA/LP Proteins bei der autoimmunen Hepatits untersucht. Zum einen sollte die Hypothese einer aberranten Expression des SLA/LP Moleküls als Auslöser der Autoimmunreaktion gegen SLA/LP überprüft werden. Hierzu wurde die Expression des SLA/LP Moleküls in Leber und Lymphozyten von Patienten mit verschiedenen hepatischen Erkrankungen und bei gesunden Personen bestimmt. Die quantitativen Expressionsanalysen wurden mittels real-time PCR unter Einsatz SLA/LP-spezifischer Oligonukleotide durchgeführt. Es zeigte sich, dass SLA/LP ubiquitär im Körper exprimiert wird, mit erhöhter Expression im Pankreas. Die Ergebnisse der SLA/LP Expressionsanalysen in peripheren mononukleären Blutzellen und Leberparenchymzellen von Patienten mit einer autoimmunen Hepatitis ergaben keine Hinweise auf eine aberrante Expression des SLA/LPs. Es konnte gezeigt werden, dass SLA/LP im Leberparenchym der Patienten tendenziell eher erhöht exprimiert wird, doch war kein Unterschied zwischen unterschiedlichen hepatischen Erkrankungen nachweisbar. Somit konnte in dieser Arbeit gezeigt werden, dass eine aberrante Expression nicht für die Auslösung der Erkrankung zuständig ist. Zum andern sollte in dieser Arbeit überprüft werden, ob eine Autoimmunreaktion gegen SLA/LP zu einer Entzündung in der Leber führen kann. Hierzu wurden Mäuse unterschiedlicher Stämme mit SLA/LP Protein in komplettem Freunds Adjuvans immunisiert und auf Leberschädigung und Leberentzündung untersucht. Es konnte gezeigt werden, dass SLA/LP-Autoimmunität Leberentzündung und Leberschädigung auslösen kann. Die Auslösung der Hepatitis war aber vom Mausstamm und der Defizienz von Interleukin 10 abhängig. Somit scheint unter bestimmten immunologischen Bedingungen eine Immunreaktion gegen SLA/LP zu einer Leberentzündung und Leberschädigung zu führen.

The Euler number of OGradys 10-dimensional symplectic manifold

Wir berechnen die Eulerzahl der 10-dimensionalen exzeptionellen irreduziblen symplektischen Mannigfaltigkeit, die von O Grady konstruiert wurde. Die Idee besteht darin, zunächst eine Lagrangefaserung zu konstruieren und dann die Eulerzahlen der Fasern zu berechnen. Es stellt sich heraus, dass fast alle Fasern die Eulerzahl 0 haben, und deswegen reduziert sich das Problem auf die Berechnung der Eulerzahlen der übrigen Fasern. Diese Fasern sind Modulräume von halbstabilen Garben auf singulären Kurven. Der Hauptteil dieser Dissertation ist der Berechnung der Eulerzahlen dieser Modulräume gewidmet. Diese Resultate sind von unabhängigem Interesse.

Toward a Magnitude Scale for Low Frequency Seismicity The LP energy for Campi Flegrei caldera

The energy released during a seismic crisis in volcanic areas is strictly related to the physical processes in the volcanic structure. In particular Long Period seismicity, that seems to be related to the oscillation of a fluid-filled crack (Chouet , 1996, Chouet, 2003, McNutt, 2005), can precedes or accompanies an eruption. The present doctoral thesis is focused on the study of the LP seismicity recorded in the Campi Flegrei volcano (Campania, Italy) during the October 2006 crisis. Campi Flegrei Caldera is an active caldera; the combination of an active magmatic system and a dense populated area make the Campi Flegrei a critical volcano. The source dynamic of LP seismicity is thought to be very different from the other kind of seismicity ( Tectonic or Volcano Tectonic): it’s characterized by a time sustained source and a low content in frequency. This features implies that the duration–magnitude, that is commonly used for VT events and sometimes for LPs as well, is unadapted for LP magnitude evaluation. The main goal of this doctoral work was to develop a method for the determination of the magnitude for the LP seismicity; it’s based on the comparison of the energy of VT event and LP event, linking the energy to the VT moment magnitude. So the magnitude of the LP event would be the moment magnitude of a VT event with the same energy of the LP. We applied this method to the LP data-set recorded at Campi Flegrei caldera in 2006, to an LP data-set of Colima volcano recorded in 2005 – 2006 and for an event recorded at Etna volcano. Experimenting this method to lots of waveforms recorded at different volcanoes we tested its easy applicability and consequently its usefulness in the routinely and in the quasi-real time work of a volcanological observatory.